MétaCan
Menu
Back to cohort
Record W2966010326 · doi:10.1016/j.jaad.2019.04.045

Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR study

2019· letter· en· W2966010326 on OpenAlexafffund
Diamant Thaçi, L. Puig, Kristian Reich, Tsen‐Fang Tsai, Stephen K. Tyring, Külli Kingo, Michael Ziv, Andreas Pinter, Ronald Vender, A. Lacombe, Summer Xia, Vaishali Bhosekar, I. Gilloteau, Adriana Guana, Andrew Blauvelt

Bibliographic record

VenueJournal of the American Academy of Dermatology · 2019
Typeletter
Languageen
FieldImmunology and Microbiology
TopicPsoriasis: Treatment and Pathogenesis
Canadian institutionsDermatrials Research
FundersSamsung BioepisCilagJanssen BiotechBeijing Novartis PharmaSanofi GenzymeMerck Sharp and DohmeSamsungLEO PharmaMedacMitsubishi Tanabe Pharma CorporationAlmirallGaldermaAllerganTartu ÜlikoolNational Taiwan UniversitySanofiKyowa Hakko KirinEli Lilly and CompanyNational Taiwan University HospitalPurdue PharmaFresenius Medical Care North AmericaSun PharmaNovartis Pharmaceuticals CorporationDermiraUCB PharmaValeant Pharmaceuticals InternationalRegeneron PharmaceuticalsPfizerBiogenNovartisCelgenePurdue UniversityBaxaltaGenentechBiogen IdecNovartis PharmaAbbVieBoehringer IngelheimAmgenGlaxoSmithKline
KeywordsMedicineSecukinumabPsoriasisDermatologyPlaque psoriasisIntensive care medicinePsoriatic arthritis

Abstract

fetched live from OpenAlex

To the Editor: Secukinumab is a fully human monoclonal antibody that selectively neutralizes interleukin 17A, a key cytokine involved in the development of psoriasis.1 Secukinumab has shown long-lasting efficacy and safety in the complete spectrum of psoriatic disease, including disease localized to nails, scalp, palms and soles, and joints (peripheral and axial arthritis).1-3 Given the chronic and relapsing nature of psoriasis, long-term data might help to fully characterize the efficacy and safety profile of secukinumab as well as its impact on quality of life.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.011
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.009
Threshold uncertainty score0.014

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.011
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0010.001
Scholarly communication0.0010.001
Open science0.0010.000
Research integrity0.0090.008
Insufficient payload (model declined to judge)0.0030.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.012
GPT teacher head0.246
Teacher spread0.234 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations18
Published2019
Admission routes2
Has abstractyes

Explore more

Same venueJournal of the American Academy of DermatologySame topicPsoriasis: Treatment and PathogenesisFrench-language works237,207